Regulatory effects of sestrin 3 (SESN3) in BCR-ABL expressing cells.
Chronic myeloid leukemia (CML) and Ph+ acute lymphoblastic leukemia (ALL) are characterized by the presence of the BCR-ABL oncoprotein, which leads to activation of a plethora of pro-mitogenic and pro-survival pathways, including the mTOR signaling cascade. We provide evidence that in BCR-ABL expres...
Guardado en:
Autores principales: | Eliza Vakana, Ahmet Dirim Arslan, Amy Szilard, Jessica K Altman, Leonidas C Platanias |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/24052efa13034cfc8650dcc815e472d7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A Novel ELISA-Based Peptide Biosensor Assay for Screening ABL1 Activity in vitro: A Challenge for Precision Therapy in BCR-ABL1 and BCR-ABL1 Like Leukemias
por: Oksana Montecchini, et al.
Publicado: (2021) -
Major molecular response achievement in CML Patients can be predicted by BCR-ABL1/ABL1 or BCR-ABL1/GUS ratio at an earlier time point of follow-up than currently recommended.
por: Sarah Huet, et al.
Publicado: (2014) -
Characteristics of BCR–ABL gene variants in patients of chronic myeloid leukemia
por: Amin Huma, et al.
Publicado: (2021) -
Molecular Pathogenesis of BCR-ABL-Negative Atypical Chronic Myeloid Leukemia
por: Diletta Fontana, et al.
Publicado: (2021) -
A kinase-independent role for CDK8 in BCR-ABL1+ leukemia
por: Ingeborg Menzl, et al.
Publicado: (2019)